Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

GSK

GSK (GSK)

GSK plc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:GSK

<< Previous 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 Next >>

Date	Time	Source	Headline	Symbol	Company
04/01/2019	1:35PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
03/29/2019	9:03AM	Edgar (US Regulatory)	Certification by the Exchange Approving Securities for Listing (cert)	NYSE:GSK	GSK plc
03/28/2019	4:08PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
03/25/2019	2:25PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
03/25/2019	1:56PM	Edgar (US Regulatory)	Securities Registration (section 12(b)) (8-a12b)	NYSE:GSK	GSK plc
03/25/2019	1:38PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
03/21/2019	12:53PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
03/21/2019	12:47PM	Dow Jones News	GlaxoSmithKline Reports Positive Data From Blood Cancer Study	NYSE:GSK	GSK plc
03/20/2019	5:37PM	Dow Jones News	ADRs End Slightly Lower; BBVA, British American Tobacco and GlaxoSmithKline Trade Actively	NYSE:GSK	GSK plc
03/20/2019	1:56PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)	NYSE:GSK	GSK plc
03/19/2019	2:43PM	Dow Jones News	Glaxo: Tesaro Asset Dostarlimab Showing Positive Results	NYSE:GSK	GSK plc
03/19/2019	2:24PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
03/19/2019	6:05AM	Edgar (US Regulatory)	Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)	NYSE:GSK	GSK plc
03/18/2019	9:30AM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)	NYSE:GSK	GSK plc
03/18/2019	6:53AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
03/15/2019	4:27PM	Edgar (US Regulatory)	Notice of Iran-related Disclosure Filed Pursuant to Section 13(r)(3) of the Exchange Act (irannotice)	NYSE:GSK	GSK plc
03/15/2019	4:25PM	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NYSE:GSK	GSK plc
03/12/2019	1:35PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
03/12/2019	12:09PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
03/11/2019	3:03PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
03/08/2019	8:43AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
03/08/2019	2:55AM	Dow Jones News	GlaxoSmithKline Reports Positive Results From Two Phase 3 HIV Drug Studies	NYSE:GSK	GSK plc
03/05/2019	1:16PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
03/04/2019	8:15AM	GlobeNewswire Inc.	New Research: Key Drivers of Growth for GlaxoSmithKline plc, nVent Electric, Dana, FMC, Qualys, and Affiliated Managers Group...	NYSE:GSK	GSK plc
03/01/2019	8:13AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
02/22/2019	5:28PM	Dow Jones News	U.K. Closes Corruption Probes of GlaxoSmithKline, Rolls-Royce Individuals	NYSE:GSK	GSK plc
02/22/2019	1:43PM	Dow Jones News	U.K.'s Fraud Agency Won't Prosecute Individuals in Rolls-Royce Corruption Case	NYSE:GSK	GSK plc
02/22/2019	1:12PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
02/22/2019	10:19AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NYSE:GSK	GSK plc
02/22/2019	7:07AM	Dow Jones News	Glaxo: UK Fraud Agency Closes Bribery Probe Into Company	NYSE:GSK	GSK plc

Showing the most relevant articles for your search:NYSE:GSK

<< Previous 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 Next >>

Seafarer Exploration (PK)

Asia Broadband (PK)

Moon Equity (PK)

Code Green Apparel (PK)

Maxeon Solar Technologies

Ronn Motor (PK)

FuelCell Energy

Progressive Care (QB)

TPT Global Tech (PK)

Impact Fusion (PK)

Virexit Technologies (PK)

Rennova Health (PK)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions